****
**Go to PREVLINE's...Home PageWhat's NewGirl Power!Reality CheckNewsroom-- for MediaDatabasesResearch Briefs###############Alcohol & Drug FactsConference CalendarFunding/GrantsLatest ResearchOnline ForumsRelated LinksResources & ReferralsSite/Web SearchWhat's NewWorkplace Issues###############CSAP's CAPTsCSAT TIP SeriesPEPS - CommunitiesPEPS - Practitioners###############Contact NCADINCADI ServicesFeedbackSAMHSA Media ServicesPublications Series- Alcohol Alert Series  Substance Abuse Resource GuidesCSAP Prevention Monographs
- CSAP Technical Report Series  CSAP Communications Technical Assistance BulletinsCSAP Drug-Free Communities Series
- NIDA Infofax  NIDA Research Monograph SeriesNIDA Research Report Series
- NIDA's Mind Over Matter Series  CSAT Technical Assistance Publications SeriesCSAT Treatment Improvement Publications Series
- SAMHSA Managed Care Technical Assistance Series       NIAAA Alcohol Alert Series    - **Alcohol Alert #11. Estimating the Cost of Alcohol Abuse**  (1990) 6 pp.  PH293  The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.    **Alcohol Alert #15. Alcohol and AIDS** (1992) 4 pp. **PH311**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #16. Moderate Drinking**
 (1992) 4 pp. 
PH315
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. 
- **Alcohol Alert #17. Treatment Outcome Research**  (1992) 4 pp.  PH322  **Alcohol Alert #18. The Genetics of Alcoholism** (1992) 4 pp. **PH328**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #19. Alcohol and the Liver**
 (1993) 4 pp. 
PH329
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. 
- **Alcohol Alert #21. Alcohol and Cancer**  (1993) 4 pp.  PH345  **Alcohol Alert #23. Alcohol and Minorities** (1994) 4 pp. **PH347**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #24. Animal Models in Alcohol Research**
 (1994) 4 pp. 
PH350
- **Alcohol Alert #25. Alcohol-Related Impairment**  (Reprint 1996) 4 pp.  PH351  The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.    **Alcohol Alert #26. Alcohol and Hormones** (1994) 4 pp. **PH352**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #27. Alcohol Medication Interactions**
 (1995) 4 pp. 
PH355
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. 
- **Alcohol Alert #28. Alcohol and Tolerance**  (1995) 4 pp.  PH356  The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.    **Alcohol Alert #29. College Students and Drinking** (1995) 4 pp. **PH357**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #30. Diagnostic Criteria for Alcohol Abuse and Dependence**
 (1995) 4 pp. 
PH359
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. 
- **Alcohol Alert #31. Drinking and Driving**  (1995) 4 pp.  PH362  The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.    **Alcohol Alert #32. Alcohol and Stress** (1995) 4 pp. **PH363**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #33. Neuroscience Research and Medications Development**
 (1996) 4 pp. 
PH366
- **Alcohol Alert #34. Preventing Alcohol Abuse and Related Problems** (1996) 6 pp. **PH370**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #35. Alcohol Metabolism**
 (1997) 4 pp. 
PH371
- **Alcohol Alert #36. Patient-Treatment Matching** (1997)  PH375  The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.    **Alcohol Alert #37. Youth Drinking: Risk Factors and Consequences**(1997) **PH376**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. **Alcohol Alert #38. Alcohol, Violence, and Aggression**
(1997) 
PH377
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. 
- **Alcohol Alert #39. Alcohol and Tobacco** (1997)  PH378  The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.    **Alcohol Alert #40. Alcohol and Aging**(1998) **PH379****Alcohol Alert #41. Alcohol and Sleep**
(1998) 
PH380
- **Alcohol Alert #42. Alcohol and the Liver: Research Update** (1998)  PH381   **Alcohol Alert #43. Brief Intervention for Alcohol Problems**(1999) **PH382****Alcohol Alert #44. Alcohol and the Workplace**
(1999) 4 pp. 
PH383
- .Alcohol Alert #45. Alcohol and Coronary Heart Disease(1999) 4 pp. **PH385**
***Back to Top***
CSAP Substance Abuse Resource Guides
These Resource Guides typically contain sections on Prevention Materials; Studies, Articles, and Reports; and Groups, Organizations, and Programs. Each guide focuses on one special population or topic as it relates to substance abuse. 
- **African Americans**(1996, CSAP) 20 pp. **MS459**This guide lists prevention resources specifically for the African-American community.**Alcohol and Other Drug-Related Periodicals**
(1992) 12 pp. 
MS449
The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. 
The AOD prevention field will find this guide useful for tracking down relevant information and keeping on top of the latest developments.
- **American Indians and Native Alaskans**  (1998) 28 pp.  MS419  American Indians and Native Alaskans have a proud heritage as the original inhabitants of our country. Members of these communities are also at great risk of alcohol and drug abuse. **Asian and Pacific Islander Americans**(1996) 13 pp. **MS408**Resources appropriate for use in Asian American and Pacific Islander American communities are contained in this guide.
**Child Abuse**(1995) 26 pp. **MS448**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. Alcohol and drug abuse and child abuse are often closely related. This guide provides information and assistance for persons trying to curb the incidence of both problems.**Community Action**
(1996) 20 pp. 
MS460
This resource guide is designed for community leaders, volunteers, and ordinary citizens who are concerned about alcohol and drug problems in their neighborhoods.
-  **Elementary Youth**   (CSAP, 2000) 22 pp.  MS421  Unfortunately, children in our country are being exposed to drugs at younger ages than ever before. Many times, their first interaction with illegal substances comes as early as elementary school. The latest in a series of Substance Abuse Resource Guides from the Center for Substance Abuse Prevention, Elementary Youth is filled with resources designed to prevent substance abuse, and to help build a strong anti-drug sentiment in young children.  **Employee Assistance Programs**(1992) 25 pp. **MS439**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. This guide provides useful information for employers and EAP professionals who wish to address the issue of AOD use in the workplace.**Faith Communities**
(1997) 25 pp. 
MS457
Faith and religion play an enormous role in the lives of many individuals. This resource guide will help members and leaders of faith communities to reach people in their congregations and neighborhoods.
- **Foundations**   (1992) 18 pp.  MS447   The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE.   Private and nonprofit organizations are great supporters and advocates in the AOD prevention effort. The  Foundations  resource guide provides information and suggestions for these associations, including ideas related to fundraising, leadership training, forming partnerships, and effective grant writing. **Healthcare Providers**(1995) 24 pp. **MS486**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. This resource guide is targeted to healthcare providers who educate peopole in their community about the effects of alcohol, tobacco, and drug use.**Hispanic/Latino Americans**
(1996) 32pp. 
MS441
This resource guide provides information and referrals to help prevention specialists, educators, and community leaders better meet the needs of the Hispanic/Latino community living in the United States.
- **Impaired Driving**   (1991) 20 pp.  MS434  The  Impaired Driving  resource guide contains data on automobile crashes caused by intoxication or drug use. **Inhalants**(1994) 14 pp. **MS466**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. Youth are using regular household, office, and classroom products to get high, and many are suffering the damaging effects to the heart, kidney, liver, and brain. This guide provides information about inhalant use.**Injury Control**
(1995) 20 pp. 
MS485
Alcohol and drugs are associated with injuries ranging from drinking and driving accidents to falls, drownings, and suicides. This resource guide provides information emphasizing safety.
- **Lesbians, Gay Men, and Bisexuals**   (1994) 44 pp.  MS489  Lesbians, gay men, and bisexuals face particular barriers to alcohol, tobacco, and drug abuse prevention and treatment programs. This population has endured stigma, denial, alienation, and discrimination, all of which can place them at a high risk for ATD abuse. This guide will increase understanding of the issues important to the lesbian, gay, and bisexual communities. **Managed Care and Prevention**(1998) 48 pp. **MS623**The information in this resource guide will help prevention professionals understand that their skills and leadership are essential to complete the evolutionary cycle from managing healthcare costs to managing the health of citizens.**Marijuana**
(1997) 25 pp. 
MS545
Marijuana is being used increasingly by large numbers of very young teens. Use of marijuana by youth is disruptive to their psychological, social, and academic well-being. This guide offers information and referrals designed to prevent and reduce marijuana use among youth.
- **Older Americans**   (1997) 25 pp.  MS443  Americans ages 65 and older represent roughly 12 percent of the U.S. population and are the fastest-growing segment of society. This resource guide is designed to help prevent alcohol, illicit drug, and prescription drug abuse within this population. **Parents, Guardians, and Caregivers**(1996) 20 pp. **MS503**Parents and guardians influence the attitudes and behavior of their children. This resource guide encourages parents to help their children learn skills that will help discourage alcohol, tobacco, and drug use.**People with Disabilities**
(1993) 20 pp. 
MS461
The burdens that ATD use pose are compounded when individuals have one or more physical or mental disability. This guide is designed for anyone who works with people with disabilities, including counselors, physical therapists, and mental health professionals.
- **Positive Youth Activities**   (1998) 42 pp.  MS615  Young people need adult involvement in their lives more than ever. Keeping youth busy through structured positive activities such as sports, the arts, and community service help to keep them drug-free. This guide was created to help readers incorporate positive activities into their drug abuse prevention strategies. **Pregnant/Postpartum Women and Their Infants**(1997) 24 pp. **MS420**The use of alcohol, tobacco, and drugs during pregnancy is a leading preventable cause of mental, physical, and psychological impairments and problems in infants and children. This guide targets healthcare providers, prevention program planners, and couselors of pregnant and postpartum women.**Prevention in the Workplace**
(1999) 30 pp. 
MS704A
Use of drugs and alcohol affects individuals and their work performance. This guide provides employers with resources for preventing ATD problems in the workplace.
- **Rural Communities**   (1994) 28 pp.  MS416  About 27 percent of the U.S. population live in rural regions of the country. These people face challenges unique to their area—geographic isolation, lack of availabile resources and activity, and a relative absence of anonymity—which often leads to alcohol and drug abuse. This guide explores prevention in rural communities and provides related information and referrals. **Secondary School Students**(1995) 32 pp. **MS423**This resource guide provides information specifically for secondary school students. By staying away from alcohol, tobacco, and drugs, these youth can reach their highest potential.**Tobacco**
(1999) 24 pp. 
MS704
Tobacco use is the leading preventable cause of death in the United States. This guide highlights the latest research, materials, programs, and organizations that focus on tobacco use prevention.
- **Women**   (1993) 32 pp.  MS433  More that 6 million American women suffer from alcoholism. This resource guide provides information about the effects of alcohol and drugs on women. **Youth in Low Income Environments**(1995) 25 pp. **MS446**Youth in low income urban settings face tremendous economic, social, environmental, and familial complications that put them at high risk for developing alcohol, tobacco, and drug problems. This guide provides related information for persons working with youth in low income environments.***Back to Top***
CSAP Prevention Monographs
**Communicating About Alcohol and Other Drugs: Strategies for Reaching Populations at Risk. CSAP Prevention Monograph 5**(1992) 402 pp. **BK170**This monograph represents a three-pronged initiative to 1) identify the knowledge, attitudes, and practices of youth (and their families) at special risk for developing substance abuse problems; 2) identify gaps in messages and materials; and 3) recommend strategies to reach these populations. The focus is on reaching children of alcoholics, African-American youth, Hispanic youth, parents, and health care providers. 

**Preventing Adolescent Drug Use: From Theory to Practice. CSAP Prevention Monograph 8**(1991) 270 pp. **BK185***Preventing Adolescent Drug Use* explores the complex world of adolescents and their families and the transitions that influence their development and behavior, and the factors that place them at risk for substance abuse and addiction. The monograph also contains practical information about methods of identifying, reaching, retaining, and serving youth, and the importance of early intervention. 

**Crack Cocaine: A Challenge for Prevention. CSAP Prevention Monograph 9**(1991) 71 pp. **BK190**The history and epidemiology of crack cocaine is presented in this report, which also demonstrates aspects of the drug and its use that pose unique concerns to the field of prevention. Monograph 9 examines problems specific to crack cocaine that require specially focused prevention strategies and recommendations for a crack cocaine research agenda. 

**A Promising Future: Alcohol and Other Drug Problem Prevention Services Improvement. CSAP Prevention Monograph 10**(1992) 127 pp. **BK191**This volume includes discussions of the economic and human costs of substance abuse-related problems and how these costs have led to increased Federal Government support for substance abuse prevention. It also addresses the prevention of HIV infection and the clinical epidemiology of drug abuse and AIDS. 

**Identifying the Needs of Drug Affected Children: Public Policy Issues. CSAP Prevention Monograph 11**(1992) 169 pp. **BK195**Monograph 11 is based on papers and discussions from CSAP's first Issues Forum held in November 1990, which brought experts together to define the needs of substance abuse exposed children ages 2 to 5. The monograph describes the problem, our current solutions, and suggestions of what needs to be done about this growing problem. 

**The Second National Conference on Preventing and Treating Alcohol and Other Drug Abuse, HIV Infection, and AIDS in Black Communities: From Advocacy to Action. CSAP Prevention Monograph 13**(1992) 500 pp. **BKD078**This monograph of conference presentations describes initiatives against substance abuse, HIV infection, and AIDS in African-American communities. Experts discuss resources to convert prevention and treatment knowledge into practical efforts to eradicate these problems from communities nationwide. 

**Experiences with Community Action Projects: New Research in the Prevention of Alcohol and Other Drug Problems. CSAP Prevention Monograph 14**(1993) 301 pp. **BKD087**Based on the second international research symposium, this monograph is the sequel to CSAP Prevention Monograph 4 and the first symposium. Following the format of the conference, papers are organized under broad headings: conceptual issues in evaluating community action; experiences with policy adoption case studies; community trials design issues; and needs assessments or natural experiments in special settings. 
***Back to Top***
CSAP Technical Report Series
**Breaking New Ground for Youth at Risk: Program Summaries. CSAP Technical Report 1**(1992) 137 pp. **BK163***Breaking New Ground* summarizes the 130 demonstration grants funded by CSAP in 1987, to develop, test, and evaluate approaches for working with youth in high-risk environments. Prevention, intervention, and treatment programs, as well as comprehensive, community-wide projects, are examined. 

**Urine Specimen Collection Handbook for Federal Workplace Drug Testing Programs. CSAP Technical Report 12**(1996, CSAP) 54 pp. **PHD730**The collector of urine specimens is key to the success of a drug-testing program and is the one individual with whom all donors will have direct, face-to-face contact. This handbook provides guidance to collectors in accordance with the Mandatory Guidelines for Federal Workplace Drug Testing Programs. 

**A Review of Alternative Activities and Alternative Programs in Youth Oriented Prevention. CSAP Technical Report 13**(1996) 44 pp. **PHD731**Youth who participate in alternative activities tend to be less likely to use alcohol, tobacco, and drugs. Alternative programming involves activities, programs, and events that are free of alcohol, tobacco, and drugs. Designed for policymakers and service providers, this report explores alternative programming as a means of preventing substance abuse.

**Medical Review Officer Manual for Federal Workplace Drug Testing Programs. CSAP Technical Report 15** (1997, CSAP) 72 pp. **PHD748**This manual covers the medical review officer's (MRO's)  involvement in the review and interpretation of drug testing results. Guidelines, the review process, specific drug class issues, specimen issues, and documentation and recordkeeping are discussed. 
***Back to Top***
CSAP Communications Technical Assistance Bulletins
This series of short informational bulletins will assist program planners in developing substance abuse prevention materials. Currently, the series includes 11 titles that can be ordered (**MS490**) in a shrink-wrapped kit. The kit also contains an insertable notebook cover and spine. In addition, bulletins can be ordered individually; see corresponding order numbers below. All bulletins are black text on white paper—-perfect for photocopying, and three-hole punched for easy assembly into a three-ring binder. 

Items in the shrink-wrapped kit include:

**A Discussion Guide Can Enhance Your Presentation**(Reprint 1994) 4 pp. **MS496**Discussion guides help clarify and reinforce the message that is presented and can be used with videotapes, films, puppet shows, plays, or skits. This bulletin explains the typical contents of a discussion guide as well as tips for handling the discussion. 

**A Key Step in Developing Prevention Materials Is To Obtain Expert and Gatekeeper Reviews**(Reprint 1994) 8 pp. **MS492**This bulletin provides a step-by-step process for obtaining advice from expert reviewers or gatekeepers. It lays the groundwork for a successful review procedure and includes recommendations for identifying qualified experts and getting their help. 

**Careful Concept Development Paves the Way to Effective Prevention Materials**(1994) 8 pp. **MS493**Using a concept development process based on established health communication principles can help create products that convey the right message to the right people. This bulletin outlines a process for generating ideas, identifying options, considering different approaches, and making conscious choices before making final decisions about the development of prevention materials. 

**Conducting Focus Groups with Young Children Requires Special Considerations and Techniques**(Reprint 1994) 12 pp. **MS501**This bulletin discusses ways to modify standard techniques to accommodate the special needs of and concerns for children ages 5-12. 

**Following Specific Guidelines Will Help You Assess Cultural Competence in Program Design, Application, and Management**(1994) 4 pp. **MS500**The bulletin presents seven indicators or guidelines that program developers, evaluators, and managers can use to gauge whether a program is operating from a culturally competent base. The bulletin explains why culture should be a consideration in assessing prevention programs and describes the cultural elements that are essential to an overall evaluation. 

**Pretesting Is Essential; You Can Choose from Various Methods**(Reprint 1994) 8 pp. **MS498**Pretesting can be used to design effective substance abuse prevention messages and materials. This bulletin presents six methods from which to choose and discusses factors to consider in selecting the appropriate pretesting methods.  

**You Can Avoid Common Errors As You Develop Prevention Materials**(Reprint 1994) 8 pp. **MS497**This bulletin focuses on the public health principles and guidelines with which prevention programmers most often fail to comply in the development of messages and materials.  This bulletin also provides examples to illustrate clear, positive communication, as well as the mixed communication that should be avoided. 

**You Can Increase Your Media Coverage**(1994) 8 pp. **MS491***You Can Increase Your Media Coverage* explains how reviewing the basic tools of media relations can ensure good media coverage. The bulletin discusses the importance of creating a media list, using proactive approaches, selecting spokespersons, and developing relationships with reporters, editors, publishers, and producers. 

**You Can Manage Focus Groups Effectively for Maximum Impact** (Reprint 1994) 8 pp. **MS495**This bulletin provides an overview of what focus group managers need to consider when using focus groups to gauge audience opinions, knowledge, and feelings toward prevention messages and materials. 

**You Can Prepare Easy-To-Read Materials**(Reprint 1994) 8 pp. **MS499**Everyone benefits from materials that are clear and concise. This bulletin presents a five-step approach, including the SMOG readability formula, to ensure that the target audience understands the substance abuse prevention message as the developer intended.  

**You Can Use Communication Principles To Create Culturally Sensitive and Effective Prevention Materials**(Reprint 1994) 12 pp. **MS494**This bulletin explores the role that culture plays in shaping an individual's attitudes and values. The bulletin also suggests techniques for targeting audiences and provides specific steps for developing culturally appropriate messages and materials using the health communications process. 

Other Bulletins not available in the shrink-wrapped kit include:

**Communicating Appropriately With Asian and Pacific Islander Audiences**(1997) 12 pp. **MS701**It is important to recognize and respect the geographic, ethnic, cultural, social, and linguistic diversity of Asian and Pacific Islander audiences. This bulletin discusses the challenges of creating prevention messages and products in the context of varying cultures and other factors. The bulletin also talks about substance abuse patterns and the impact of immigration. 

**Developing Effective Messages and Materials for Hispanic/Latino Audiences**(1997) 12 pp. **MS703**Hispanics/Latinos make up a multicultural community that is the product of an ongoing process of simultaneous migration from many difference countries, including Mexico, Cuba, and Puerto Rico, among others. This bulletin explains the challenges of reaching specific groups within this diverse community. The bulletin also explains how to define the target audience, create relevant messages, and get materials into the community. 

**Evaluating the Results of Communication Programs**(1998) 16 pp. **MS706**This bulletin describes how to plan and conduct outcome evaluation. It also explains the benefits of conducting outcome evaluation to document the results of communication efforts. 

**Identifying the Target Audience**(1997) 6 pp. **MS700***Identifying the Target Audience* is designed to help users figure out who they need to reach and why, and if and when to divide the larger audience into segments. The bulletin also shows  how to find out more about an audience, so that appropriate prevention messages can be created. 

**Urban Youth Public Education for the African American Community**(1997) 6 pp. **MS702**This bulletin talks about the importance of involving everyone in the community—youth, adult role models, churches, businesses, the media—in substance abuse prevention efforts. Also suggests ways to conduct a similar campaign in the local community. 

**Working with Mass Media**(1998) 24 pp. **MS708**Ensuring good media coverage and effectively handling communications in a crisis is vital. This bulletin presents media planning information to ensure good media coverage in urban and rural settings. 
***Back to Top***
CSAP Drug-Free Communities Series
**Prevention Plus III: Assessing Alcohol and Other Drug Prevention Programs at the School and Community Level**(1991) 470 pp. **BK188**Provides up-to-date tools and techniques for substance abuse prevention, planning, and implementation. Helps to demystify the program evaluation process and encourages participation by all members of the community. For school and community leaders, individuals, and communities that want to get involved. 
***Back to Top***
NIDA Infofax
The National Institute on Drug Abuse (NIDA) reports the latest research findings on treatment and prevention research, epidemiology, and behavioral pharmacology in ***NIDA Infofax*.  All are concise (2-4 pages) fact sheets that will keep prevention and treatment practitioners, clinicians, researchers, administrators, and policy makers up-to-date on advances in the field. These items are available separately, or in sets as follows:**NIDA Infofax Set: General Drug Information  NIF01**Spanish version--**Información general sobre drogas**, **NIF01S**- NIDA Infofax: Understanding Drug Abuse and Addiction  NIF05   Health Effects of Specific Drugs:    - NIDA Infofax: Cigarettes and Other Nicotine Products   NIF010    Spanish version-- Cigarillos y otros productos de tabaco ,  NIF010S  NIDA Infofax: Crack and Cocaine**NIF011**Spanish version--Crack y cocaína, **NIF011S**NIDA Infofax: Heroin 
NIF012
Spanish version--
Heroína
, 
NIF012S
- NIDA Infofax: Inhalants   NIF013    Spanish version-- Inhalantes ,  NIF013S  NIDA Infofax: LSD **NIF014**Spanish version--LSD, **NIF014S**NIDA Infofax: Marijuana 
NIF015
Spanish version--
Marihuana
, 
NIF015S
- NIDA Infofax: Methamphetamine  NIF016    Spanish version-- Metanfetamina ,  NIF016S  Other Drugs:    - NIDA Infofax: Ecstasy   NIF017    Spanish version-- Éxtasis ,  NIF017S  NIDA Infofax: Pain Medications **NIF018**Spanish version--Medicamentos para el dolor, **NIF018S**NIDA Infofax: PCP 
NIF019
Spanish version--
Fenciclidina (PCP)
, 
NIF019S
- NIDA Infofax: Ritalin   NIF020    Spanish version-- Ritalin ,  NIF020S  NIDA Infofax: Rohypnol and GHB **NIF021**Spanish version--Rohypnol y gammahidroxibutirato, **NIF021S**NIDA Infofax: Steroids (Anabolic)
NIF022
Spanish version--
Esteroides (Anabólicos)
, 
NIF022S
- NIDA Infofax: Drug Abuse and AIDS   NIF024    Spanish version-- El abuso de drogas y el SIDA ,  NIF024S     **NIDA Infofax Set: Treatment and Prevention  NIF02**Spanish version--Tratamiento y prevención, **NIF02S**- NIDA Infofax: Treatment Methods   NIF032  NIDA Infofax: Treatment Medications **NIF033**Spanish version--Medicamentos terapéuticos, **NIF033S**NIDA Infofax: Behavioral Change Through Treatment 
NIF034
Spanish version--
Modificación de la conducta por medio de tratamiento
, 
NIF034S
- NIDA Infofax: Treatment Methods for Women   NIF035    Spanish version-- Métodos de tratamiento para la mujer ,  NIF035S  NIDA Infofax: Lessons From Prevention Research **NIF036**Spanish version--Enseñanzas de investigaciones sobre la prevención, **NIF036S**
**NIDA Infofax Set: Statistics and News Releases  NIF03**Spanish version--Estadítucas y comunicado de noticias, **NIF03S***Survey Data:*- NIDA Infofax: Costs to Society From Drug Abuse   NIF038    Spanish version-- Costos del abuso de drogas para la sociedad ,  NIF038S  NIDA Infofax: High School and Youth Trends **NIF039**NIDA Infofax: Hospital Visits and Deaths 
NIF040
Spanish version--
Consultas y defunciones en los hospitales
, 
NIF040S
- NIDA Infofax: Nationwide Trends   NIF041    Spanish version-- Tendencias nacionales ,  NIF041S  NIDA Infofax: Pregnancy and Drug Use Trends **NIF042**Spanish version--El embarazo y las tendencias de uso de drogas, **NIF042S**NIDA Infofax: Treatment Trends 
NIF043
Spanish version--
Tendencias de tratamiento
, 
NIF043S
- NIDA Infofax: Workplace Trends   NIF044    Spanish version-- Tendencias en el lugar de trabajo ,  NIF044S   News Releases:     - NIDA Infofax: Scientists Identify Gene Involved in Sensitivity to Cocaine   NIF045  NIDA Infofax: Economic Costs of Alcohol and Drug Abuse Estimated at $236 Billion in the United States **NIF046**NIDA Infofax: Severity of Brain Changes During Nicotine Withdrawal Comparable to Those for Other Drugs of Abuse 
NIF047
- NIDA Infofax: New Help Available for Communities to Assess Local Drug Problems   NIF048  NIDA Infofax: Troubled Teens Risk Rapid Dependence on Marijuana **NIF049**NIDA Infofax: Study Identifies Mechanism for Cocaine-Induced Stroke and Other Brain Damage 
NIF050
- NIDA Infofax: One Step Closer to Unraveling Nicotine's Addictive Properties   NIF051  NIDA Infofax: Drug Use Survey Shows Mixed Results for Nation's Youth  **NIF052**NIDA Infofax: New Research Documents Success of Drug Abuse Treatments  
NIF053
NIDA
NIDA Infofax: NIDA Funding Opportunities 
NIF054
Spanish version--
Oportunidades de finaciamiento del NIDA
, 
NIF054S
- NIDA Infofax: Information About NIDA Grants   NIF055  NIDA Infofax: NIDA's Home Page on the World Wide Web **NIF056**Spanish version--La página de presentación del NIDA en la telaraña mundial, **NIF056S**NIDA Infofax: Our Mission and Structure 
NIF057
Spanish version--
Nuestra misión y estructura orgánica
, 
NIF057S
- NIDA Infofax: NIDA's Opportunities for Special Populations   NIF058    Spanish version-- Oportunidades del NIDA para poblaciones especiales ,  NIF058S  NIDA Infofax: Upcoming Events and Conferences **NIF061**NIDA Infofax: Other Drug Abuse Information Services 
NIF062
Spanish version--
Otros servicios de información sobre el abuso de drogas
, 
NIF062S
***Back to Top***
NIDA Research Monograph Series
**Adolescent Drug Abuse:  Analyses of Treatment Research. NIDA Research Monograph 77**(Reprint 1994) **M077**This monograph presents an overview of adolescent drug abuse treatment research and points out the many difficulties associated with adolescent clinical studies.  The monograph also reviews research on the various steps in the treatment process assessment, treatment selection, treatment delivery, and aftercare. 

**Compulsory Treatment of Drug Abuse: Research and Clinical Practice. NIDA Research Monograph 86**(Reprint 1994) **M086**Volume 86 of the NIDA Research Monograph series explores the efficacy of compulsory treatment for drug abusers. This report includes studies of the influence of coercion on a variety of treatment outcomes, as well as the costs and potential benefits of compulsory treatment. 

**AIDS and Intravenous Drug Abuse:  Future Directions for Community-Based Prevention Research. NIDA Research Monograph 93**(Reprint 1994) **M093**Successful models in prevention/outreach for AIDS education for drug abusers and training for drug treatment personnel are presented in this monograph. It also describes strengths and weaknesses of the programs and the salient issues to consider when establishing such a program. 
**Problems of Drug Dependence, 1989. NIDA Research Monograph 95**(1990) 727 pp. **M095**The *Problems of Drug Dependence, 1989* monograph contains papers presented at the 51st Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Topics covered include use of animals in research, the 1988 Anti-Drug Abuse Act, current alcoholism research, illicit drug contamination, NIDA's Medication Development Program, drug testing, opioid receptors, and physical actions of cocaine and cocaine treatment issues. 
**The Collection and Interpretation of Data from Hidden Populations. NIDA Research Monograph 98**(1990) 162 pp. **M098**This monograph addresses qualitative approaches to the study of drug abuse. Volume 98 focuses on techniques designed to access "hidden populations," such as the homeless and transient, the mentally ill, school dropouts, and other "street people." 

**Cardiovascular Toxicity of Cocaine: Underlying Mechanisms. NIDA Research Monograph 108**(1991) 238 pp. **M108**Based on an August 9-10, 1989 technical review meeting entitled *Cardiovascular Toxicity of Cocaine: Underlying Mechanisms*, this monograph consists of a collection of research papers presented at the meeting. Chapters discuss the maternal-fetal cardiovascular system, cocaine-induced myocardial depression, and the effects of cocaine on the physiology of exercise.

**Molecular Approaches to Drug Abuse Research, Volume I. NIDA Research Monograph 111**(1991) 223 pp. **M111**This monograph is based on the proceedings of a NIDA technical review that assessed current drug abuse research on the molecular level, including receptor cloning, neurotransmitter expression, and molecular genetics. This research promises to yield new understanding of the underlying basis of addiction and consequences of long-term abuse. 

**Emerging Technologies and New Directions in Drug Abuse Research. NIDA Research Monograph 112** (1991) 335 pp. **M112***Emerging Technologies* presents the proceedings of a NIDA technical review that discussed the impact of new technological advances on drug abuse research. The papers focus on innovative methodologies—from biological cloning techniques to computer-aided imaging—that could alter the current and future directions and applications of research related to drugs of abuse. 

**Methodological Issues in Controlled Studies on Effects of Prenatal Exposure to Drug Abuse. NIDA Research Monograph 114**(1991) 372 pp. **M114**Prenatal exposure to drugs of abuse has adversely affected the lives of hundreds of thousands of babies born each year in the United States to drug-dependent mothers. This report presents the proceedings of the first NIDA technical review related to the conduct of controlled studies on the effect of prenatal exposure to drugs of abuse. 

**Drug Discrimination: Application to Drug Abuse Research. NIDA Research Monograph 116**(1992) 408 pp. **M116**This monograph is the first to address drug discrimination. The report deals primarily with the techniques and findings of experiments that analyze how organisms discriminate drugs from other substances and placebos. 

**Methodological Issues in Epidemiological, Prevention, and Treatment Research on Drug Exposed Women and Their Children. NIDA Research Monograph 117**(1992) 399 pp. **M117***Methodological Issues* discusses the effects of prenatal exposure to drugs; physical and behavioral aspects of the mother, child, and their relation to each other; intervention issues; and legal issues affecting women whose drug use has affected their children. 

**Molecular Approaches to Drug Abuse Research, Volume II. NIDA Research Monograph 126**(1992) 164 pp. **M126**This monograph summarizes recent progress in drug abuse research achieved through molecular approaches; reviews relevant technological advances in the field of molecular biology and genetics; and introduces promising new research areas. 

**Progress and Issues in Case Management. NIDA Research Monograph 127**(1992) 412 pp. **M127**Volume 127 of this series discusses research studies on case management in the areas of street outreach, treatment, waiting list reduction, and criminal justice. The monograph suggests various models of case management and discusses the benefits of case management. 

**Impact of Prescription Drug Diversion Control Systems on Medical Practice and Patient Care. NIDA Research Monograph 131**(1993) 343 pp. **M131**This report discusses the impact of prescription drug abuse on public health and the systems in place to minimize abuse and its impact on patient care. It also explores the gaps in our ability to evaluate existing diversion control systems. 

**Medications Development: Drug Discovery, Databases, and Computer-Aided Drug Designs. NIDA Research Monograph 134**(1993) 274 pp. **M134***Medications Development* discusses the drug discovery process and new techniques and technologies used to develop medications for drug abuse treatment. 

**Assessing Neurotoxicity of Drugs of Abuse. NIDA Research Monograph 136**(1993) 281 pp. **M136**Various methodologies are used to research the neurotoxicity of drugs of abuse. This monograph explores the methods used to determine the neurotoxicity of several abused substances, including amphetamine and its congeners, tetrahydro-cannabinol, and phencyclidine. 

**Imaging Techniques in Medications Development: Preclinical and Clinical Aspects. NIDA Research Monograph 138**(1994) **M138**This report discusses imaging techniques such as PET, SPECT, and MRI with special emphasis on imaging of neural receptors. 

**Discovery of Novel Opioid Medications. NIDA Research Monograph 147**(1995) **M147**This report reviews the pharmacology, neuropharmacology, and molecular biology of potential pharmacotherapies for opioids, novel opioids, and non-opioids. 

**Epidemiology of Inhalant Abuse: An International Perspective. NIDA Research Monograph 148**(1995) **M148**Volume 148 in this series describes the epidemiology of inhalant use in the United States and in selected countries around the world. The monograph discusses unique problems associated with investigations of inhalant use. It also suggests methodologies that might be utilized to investigate the high risk, difficult-to-reach groups who use inhalants in various countries. 

**Integrating Behavioral Therapies with Medications in the Treatment of Drug Abuse. NIDA Research Monograph 150**(1995) **M150**Latest research findings, including state-of-the-art techniques and procedures regarding the integration of psychosocial and pharmacological treatments, are examined in this report. 

**Membranes and Barriers: Targeted Drug Delivery. NIDA Research Monograph 154**(1995) **M154***Membranes and Barriers* discusses the ability of drugs to effectively cross the various membrane barriers and reach the receptors which allow the drugs to produce biological effect(s). The monograph discusses the modern drug design techniques that make it now possible to design drugs that are selectively delivered to a specific target. Mechanisms of drug transport are also discussed in terms of prodrugs, stable drugs, peptidomimetics, etc. 

**Reviewing the Behavioral Science Knowledge Base on Technology Transfer. NIDA Research Monograph 155**(1995) **M155**This report discusses comprehensive approaches to technology transfer coming from several disciplines, including behavioral science. The monograph also covers the development of technology transfer strategies, setting them in the larger context of partnership efforts with community constituencies and overall changes in health care and information technology. 

**Adolescent Drug Abuse: Clinical Assessment and Therapeutic Interventions. NIDA Research Monograph 156**(1995) **M156***Adolescent Drug Abuse* presents an overview of clinical assessment procedures, service delivery strategies, and therapeutic interventions designed specifically for youth. Special attention is given to drug-related medical problems, cultural issues, and family involvement. 

**Qualitative Methods in Drug Abuse and HIV Research. NIDA Research Monograph 157**(1995) **M157**Volume 157 of this series reviews current applications of qualitative methods in drug abuse and HIV/AIDS prevention research. Emphasis is on the use of innovative ethnographic methods of accessing hidden populations, target sampling, identifying drug use and HIV/AIDS risk behaviors, developing culturally appropriate risk reduction messages, implementing interventions, and evaluating program results.  

**Biological Mechanisms and Perinatal Exposure to Drugs. NIDA Research Monograph 158**This item is currently out of stock.(1995) **M158**This monograph reviews the current research findings in the area of perinatal exposure to abused drugs and its impact on various biological systems during the developmental period. 

**Individual Differences in Biobehavioral Etiology of Drug Abuse. NIDA Research Monograph 159**(1996) 358 pp. **M159**The purpose of this monograph is to provide a platform of ideas from which new direction for research in the biobehavioral etiology of substance abuse can be developed.  Three research areas are discussed: genetic bases, neurophysiological correlates, and neurochemical factors underlying drug abuse risk or resistance. 

**Molecular Approaches to Drug Abuse Research, Volume III. NIDA Research Monograph 161**(1996) 232 pp. **M161**This monograph provides the highlights from the third conference on molecular approaches to drug abuse research, held in March 1994 at NIH. Cutting-edge research is presented on transgenic/knockout animal models and other genetic approaches, transporters, and opioid receptors. 

**Problems of Drug Dependence 1995:  Proceedings of the 57th Annual Scientific Meeting: The College on Problems of Drug Dependence.  NIDA Research Monograph 162**548 pp. **M162**NIDA Research Monograph 162 contains papers adapted from the symposium meetings and plenary sessions held at the 57th Annual Scientific Meeting and offers the state-of-the-art on many areas encompassing many disciplines in drug abuse research. Abstracts on various research-in-progress are also included, permitting readers to be informed of the latest research developments in the drug abuse field.  

**Neurotoxicity and Neuropathology Associated with Cocaine Abuse. NIDA Research Monograph 163**(1996) 344 pp. **M163**The monograph describes clinical, biochemical, physiological, and psychological aspects of neurotoxicity and neuropathology associated with abuse of cocaine and other psychostimulants. It proposes placing stimulants dependence in the category of neurological disorders in addition to the class of psychiatric disorders. This monograph discusses significance of neuropathologies in phenomology of drug dependence and their relevance in developing successful treatment strategies. 

**Behavorial Studies of Drug Exposed Offspring: Methodological Issues in Human and Animal Research. NIDA Research Monograph 164**(1996) 300 pp. **M164**Although the use of drugs during pregnancy has been a major public health issue in recent years, the scientific literature has been less clear partly because of complex methodological issues that confront research in this field. In July 1993 NIDA conducted a technical review from which this monograph stems. The aim of the technical review and thus the monograph is to clarify the methodological issues for future research in this field, to provide caution in the interpretation of research findings, and to suggest future research directions. 

**Beyond the Therapeutic Alliance: Keeping the Drug-Dependent Individual in Treatment. NIDA Research Monograph 165**This item is currently out of stock.(1997, NIDA) 255 pp. **M165***Beyond the Therapeutic Alliance* reviews current treatment research on the best ways to retain patients in drug dependence treatment, and to guide clinicians and clinical researchers on how to deal with this issue. The monograph addresses the issue of keeping addicted individuals in treatment long enough for the treatment to have a positive effect. 

**Treatment for Drug-Exposed Women and Their Children: Advances in Research Methodology. NIDA Research Monograph 166**(1996) 322 pp. **M166**This monograph presents a sample of what has been learned from the NIDA-funded Perinatal-20 Treatment Research Demonstration Program about: 1) services research implementation; 2) subject selection, recruitment, and retention; 3) clinical assessment and program evaluation; and 4) data management and statistical analyses. Experiences, products, and procedures used in one or more of the Perinatal-20 studies are described.  

**Rural Substance Abuse: State of Knowledge and Issues. NIDA Research Monograph 168**(1997, NIDA) 544 pp. **M168***Rural Substance Abuse* provides significant information about the special nature or context of rural communities, particularly relative to urban settings, that might impact patterns of alcohol and drug consumption and the delivery of services to prevent and treat alcohol and drug abuse. 

**Laboratory Behavioral Studies of Vulnerability to Drug Abuse. NIDA Research Monograph 169**(1998) 255 pp. **M169**This monograph provides comprehensive information on methodological and paradigmatic issues, as well as recommendations for future research directions in the field of behavioral laboratory research on vulnerability to drug abuse. 

**Meta-Analysis of Drug Prevention Programs.  NIDA Research Monograph 170**264 pp. **M170**Designed for the drug abuse prevention research and practitioner community, this monograph provides information on recent advances in research integration methods and scientific findings in the area of drug abuse prevention programs. 

**Treatment of Drug-Dependent Individual with Comorbid Mental Disorders. NIDA Research Monograph 172**170pp. **M172**This monograph promotes the effective treatment of individuals with comorbid mental and addictive disorders by reporting state-of-the science treatment research on individuals with comorbid mental and addictive disorders, and research on HIV-related issues in this population. 

**Pharmacokinetics, Metabolism and Pharmaceutics of Drug Abuse NIDA Research Monograph 173**(1997, NIDA) 316 pp.**M173**Volume 173 in this series provides the current status of research on metabolism, pharmacokinetics and pharmacodynamics of drugs of abuse. The report also addresses the ability of the drugs to effectively cross the various membrane barriers and to reach receptors depending upon the nature of the drug moiety. 

**Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting, the College on Problems of Drug Dependence, Inc. NIDA Research Monograph 174**(1997, NIDA) 462 pp. **M174**NIDA Research Monograph 174 provides proceedings from the 1996 meeting of the College on Problems of Drug Dependence. Written by meeting participants, the monograph explores a variety of topics: inhalants, nicotine, marijuana, cocaine, drug abuse and gender differences, drug abuse and adolescents, and drug abuse and pregnant women.  

**Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials. NIDA Research Monograph 175**(1997, NIDA) 329 pp. **M175**Designed for use by clinical investigators, pharmaceutical scientists, and treatment researchers, this monograph evaluates the safety and efficacy of potential treatment medications for cocaine addiction. 

**Cost-Benefit/Cost-Effectiveness Research of Drug Abuse Prevention: Implications for Programming and Policy. NIDA Research Monograph 176**(1998) 233 pp. **M176**This monograph provides definitions of prevention program types; informs policymakers, legislators, and program managers about effective prevention program strategies; and disseminates to the scientific research community a synoptic overview of the state-of-the-art of drug abuse prevention as reflected by a critical review of extant drug abuse prevention research. 

**Drug Abuse Prevention Through Family Interventions. NIDA Research Monograph 177**(1998) 523 pp. **M177***NIDA Research Monograph 177* examines ways in which family interventions may prevent drug abuse. Chapters include discussions on family etiology of youth problems, prevention of early adolescent substance abuse among high-risk youth, and selecting parenting measures for assessing family-based prevention interventions.

**Problems of Drug Dependence 1997: Proceedings of the 59th Annual Scientific Meeting of the College on Problems of Drug Dependence, Inc. NIDA Research Monograph 178**(1998) 466 pp. **M178***Problems of Drug Dependence 1997* is a yearbook of progress in drug abuse research that presents an overview of the drug abuse research field as a whole. Readers will use this publication as a summary of research progress to keep abreast of the latest developments in preclinical, clinical, social, psychological, and psychiatric aspects of drug abuse research. 

**Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting of the College on Problems of Drug Dependence, Inc. NIDA Research Monograph 179**(1999) 435 pp. **M179**This monograph is a comprehensive gathering of scientific information on all aspects of substance abuse. Chapters in the book discuss behavior change in cocaine abusers, adolescent drug abuse, tobacco use, methamphetamine, and many other issues.

**Problems of Drug Dependence 1999: Proceedings of the 61st Annual Scientific Meeting, The College on Problems of Drug Dependence**(NIDA, 2000) 476 pp. **M180***NIDA Research Monograph 180* provides abstracts of the several hundred research papers which were presented at the 61st Annual Scientific Meeting on Problems of Drug Dependence.
***Back to Top***
NIDA Research Report Series
**NIDA Research Report Series: Cocaine Abuse and Addiction**(1999) 8 pp. **PHD813**Although cocaine is one of the oldest known drugs, it has been labeled the drug of the 1980's and 1990's because of its extensive popularity and use during this period. This report examines the history of cocaine, identifies crack cocaine, and explains the effects and medical complications of cocaine use and abuse. The report also investigates the various treatments for cocaine abuse.

**NIDA Research Report Series: Heroin Abuse and Addiction**(1997) 8 pp. **PHD742**Heroin use is on the rise, particularly among youth. This report provides information on the prevalence of heroin abuse, methods of use, short- and long-term effects of abuse, and medical complications of chronic abuse. It also describes effective treatment for heroin addiction and lists resources for additional information. 

**NIDA Research Report Series: Inhalant Abuse: Its Dangers Are Nothing to Sniff at**(1994) 8 pp. **PHD675**Based upon recent research on the use and prevalence of inhalants, this research report presents information on the types of inhalants, the consequences of use, who is using inhalants, and where to get help.

**NIDA Research Report Series: Methamphetamine Abuse and Addiction**(1998) 8 pp. **PHD756**Methamphetamine abuse is a growing problem among a diverse population in urban and rural areas of the United States. This report provides scientific information on methamphetamine abuse, including current epidemiological data regarding its abuse, the short- and long-term effects of abuse, effective treatment methods, and an emphasis on how methamphetamine affects the brain. 

**NIDA Research Report Series: Nicotine Addiction**(1998) 8 pp. **PHD762**This report defines nicotine and describes current epidemiological research data regarding its use; the medical consequences of nicotine use, with an emphasis on the effects of nicotine on the brain; current research findings about use during pregnancy; and treatment approaches. 
***Back to Top***
CSAT Technical Assistance Publications Series
**Approaches in the Treatment of Adolescents with Emotional and Substance Abuse Problems. Technical Assistance Publications Series 1**(Reprint 1993) 30 pp. **PHD580**Volume 1 in this series addresses the needs of adolescents with substance abuse problems and makes practical recommendations on the implementation of effective treatment methods. 

**Need, Demand, and Problem Assessment for Substance Abuse Services.  Technical Assistance Publications Series 3**(Reprint 1993) 33 pp. **PHD582**This report documents more than a dozen methodologies designed to assist in developing more structured approaches to assessing the need for substance abuse treatment services and estimating the demand for services. 

**Coordination of Alcohol, Drug Abuse, and Mental Health (ADM) Services. Technical Assistance Publications Series 4**(1993) 32 pp. **PHD583X**The photocopied version of this TAP describes the major models and mechanisms available and makes recommendations regarding the process of developing coordination among ADM services. 

**Self-Run, Self-Supported Houses for More Effective Recovery from Alcohol and Drug Addiction. Technical Assistance Publications Series 5**(1993) 130 pp. **PHD584X**This photocopy of *Self-Run, Self-Supported* describes the experience of Oxford House and the mechanics of renting houses to be used as self-run, self-supported recovery houses. 

**Empowering Families, Helping Adolescents: Family-Centered Treatment of Adolescents with Alcohol, Drug Abuse, and Mental Health Problems. Technical Assistance Publications Series 6**This item is currently out of stock(Reprint 1994) 204 pp. **BKD81**This report describes issues, treatment models, and steps necessary to implement a family-centered approach to adolescent treatment. 
**Treatment of Opiate Addiction With Methadone: A Counselor's Manual. Technical Assistance Publications Series 7**(CSAT, 1994) 183 pp. **BKD151**A manual is presented to facilitate the training of new counselors and to improve the quality of the counseling component of methadone treatment. One of the most important starting points in developing a professional attitude regarding methadone treatment is understanding that methadone is a medication. A second, equally important fact is that methadone does not cure opiate addiction. Current U.S. Food and Drug Administration regulations require that methadone treatment be delivered within an environment that offers supportive counseling and rehabilitation services. Methadone maintenance is the treatment modality that requires the greatest understanding of the rationale and regulations surrounding its use. The rationale, procedures, regulations, and patient care guidelines for the delivery of methadone maintenance treatment are presented. Methadone detoxification is a process that often provides an entry point into the system of opiate treatment. Counselors in methadone programs need to be able to provide specialized information and counseling approaches to patients who have special problems, such as terminal illness, and special groups of patients, such as women. In addition to individual skills and commitment, the methadone program staff needs to operate as a team.

**Relapse Prevention and the Substance-Abusing Criminal Offender. Technical Assistance Publications Series 8**(1993) 30 pp. **BKD121**In volume 8 of this series, an overview of chemical addiction and the process of recovery are examined. The report also discusses the process of relapse and the principles and procedures of relapse prevention therapy. 

**Rural Issues in Alcohol and Other Drug Abuse Treatment. Technical Assistance Publications Series 10**(1994) 68 pp. **PHD662***Rural Issues* presents the papers submitted in the "Award for Excellence" competition co-sponsored by the Center for Substance Abuse Treatment and the National Rural Institute on Alcohol and Drug Abuse. Rural areas face special difficulties in providing high-quality treatment and prevention services to their widely dispersed populations. These papers address various issues and populations specific to rural settings.

**Treatment for Alcochol and Other Drug Use: Opportunities for Coordination. Technical Assistance Publications Series 11**(1994) 182 pp. **PHD663**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. This publication contains an exhaustive review of the need for and benefit of systemic coordination among State, legislative, public health, criminal justice, and social service entities in order to provide a continuum of comprehensive treatment services.

**Approval and Monitoring of Narcotic Treatment Programs: A Guide on the Roles of Federal and State Agencies. Technical Assistance Publications Series 12**(Reprint 1996) 179pp. **PHD666**This guide offers a step-by-step description of Federal and State agency rules in approving and monitoring narcotic addiction treatment programs. Contents of this TAP include a history of Federal and State involvement in narcotic treatment and an overview of the approval and monitoring process.

**Confidentiality of Patient Records for Alcohol and Other Drug Treatment. Technical Assistance Publications Series 13**(1994) 36 pp. **BKD156**The printed version of this publication is currently out of stock, however it can be viewed and printed from PREVLINE. This guide provides an overview of Federal alcohol and other drug treatment confidentiality law and regulations as well as options for resolving apparent conflicts between Federal comfidentiality requirements and State communicable disease reporting requirements. An appendix presents sample forms for patient consent and qualified service organization agreements.

**Siting Drug and Alcohol Treatment Programs: Legal Challenges to the NIMBY Syndrome. Technical Assistance Publication Series 14**The printed version of this publication is currently out of stock, however, it can still be viewed and printed on PREVline.(1995) 48 pp. **BKD175X**This photocopied TAP covers zoning and other requirements that affect siting, legal challenges to siting barriers, applying legal principles, and how to build a case.

**Forecasting the Cost of Chemical Dependency Treatment Under Managed Care: The Washington State Study. Technical Assistance Publication Series 15**(1995) 84 pp. **BKD176**Designed for State alcohol and drug agencies, this TAP provides background information and advice in using actuarial studies to predict the costs of contracting with managed care organizations. Washington State's experience in conducting an actuarial estimate of the cost of chemical dependency treatment is provided as an example. 

**Purchasing Managed Care Services for Alcohol and Other Drug Treatment: Essential Elements and Policy Issues. Technical Assistance Publication Series 16**(1995) 58 pp. **BKD167**This TAP provides an overview of managed care, current managed care/medicaid initiatives, and a managed care needs assessment. The report also discusses access, financial considerations, and consumer protections as they relate to treatment. 

**Treating Alcohol and Other Drug Abusers in Rural and Frontier Areas: 1994 Award for Excellence Papers. Technical Assistance Publications 17**(1995) **BKD174**Volume 17 of the TAP series is a compilation of papers submitted in the second nationwide Award for Excellence contest, sponsored jointly by the Center for Substance Abuse Treatment and the National Rural Institute on Alcohol and Drug Abuse. The 18 papers were submitted from a number of different regions of rural and frontier America. 

**Checklist for Monitoring Alcohol and Other Drug Confidentiality Compliance. Technical Assistance Publications Series 18**(1996) 52 pp. **PHD722X**This photocopied TAP serves as a reference for the substance abuse treatment provider on how to resolve issues of maintaining and protecting the confidentiality of patients and their records while they are seeking or receiving treatment for substance abuse.

**Counselor's Manual for Relapse Prevention With Chemically Dependent Criminal Offenders. Technical Assistance Publications Series 19**(1996) 182 pp. **PHD723**This publication focuses on chemical dependency and the criminal offender and is designed for the paraprofessional counselor. Basic counseling information is explained in simple terms. It is also designed to help the counselor work with people who are using the Appendix-Relapse Prevention Workbook for Chemically Dependent Criminal Offenders. It is based on information that has had better than average results in treating chemically dependent criminal offenders.

**Bringing Excellence to Substance Abuse Services in Rural and Frontier America: 1996 Award for Excellence Papers. Technical Assistance Publications Series 20**(1997) 137 pp. **BKD220**These papers are a culmination of the third Call for Papers from the Center for Substance Abuse Treatment and the National Rural Institute on Alcohol and Drug Abuse. The papers offer a compelling look at a number of ways in which rural and frontier America is addressing alcohol and drug abuse and the problems that accompany the abuse. 

**Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice. Technical Assistance Publications Series 21**(1998) 132 pp. **BKD246X**Addiction counselors form relationships with their clients and help them move from addiction to recovery. This TAP focuses on the work of counselors who deal with psychoactive substance use, abuse, and dependence among their clients. Chapters discuss the clinical evaluation, treatment planning, referral, and counseling.

**Contracting for Managed Substance Abuse and Mental Health Services: A Guide for Public Purchasers. Technical Assistance Publications Series 22**(1998) 295 pp. **BKD252**This TAP presents a comprehensive guide for public purchasers and others interested in influencing the development of requests for proposals (RFPs) and contracts in managed behavioral health care. The guide encourages programmatic success with chapters that cover designing, procuring, and implementing managed care systems, quality management, and consumer protections. 

**Substance Abuse Treatment for Women Offenders: Guide to Promising Practices. Technical Assistance Publication Series 23** (NOTE: Requires Adobe Acrobat Reader)(1999) 174 pp. **BKD310**This report offers guidelines and ideas for designing promising programs to help addicted women in the criminal justice system. The guide is specifically for State and community-level policymakers who plan and fund substance abuse and corrections programs.

**Welfare Reform and Substance Abuse Treatment Confidentiality: General Guidance for Reconciling Need to Know and Privacy. Technical Assistance Publication Series 24**(1999) 40 pp. **BKD336**This report provides guidance in resolving issues, faced by alcohol and drug agencies, substance abuse treatment providers, and welfare officials, related to the confidentiality of patient/client information.
***Back to Top***
 CSAT Treatment Improvement Protocol (TIP) Series 
**Pregnant, Substance-Using Women. Treatment Improvement Protocol (TIP) Series 2**(Reprint 1995) 90 pp. **BKD107**Volume 2 of this TIP defines guidelines that reflect state-of-the-art scientific and clinical knowledge on effective treatment practices and care for pregnant addicts. 
**Screening and Assessment of Alcohol and Other Drug-Abusing Adolescents. Treatment Improvement Protocol (TIP) Series 3**(Reprint 1995) 270 pp. **BKD108**For use by practitioners, this TIP offers guidelines  for screening and assessing substance-abusing adolescents and ensuring treatment and other social services. 

**Guidelines for the Treatment of Alcohol and Other Drug-Abusing Adolescents. Treatment Improvement Protocol (TIP) Series 4**(1993) 188 pp. **BKD109**This TIP defines guidelines that reflect state-of-the-art scientific and clinical knowledge to be used by practitioners for treatment of substance-abusing adolescents. 

**Improving Treatment for Drug-Exposed Infants. Treatment Improvement Protocol (TIP) Series 5**(Reprint 1995) 94 pp. **BKD110**Guidelines and standards of care in monitoring and evaluating programs treating drug-exposed infants are examined in volume 5 of this series. 
**Screening for Infectious Diseases Among Substance Abusers. Treatment Improvement Protocol (TIP) Series 6**(Reprint 1995) 160 pp. **BKD131**This TIP defines guidelines in establishing funding, monitoring, and evaluating treatment programs that screen for infectious diseases in substance abusers. 
**Screening and Assessment for Alcohol and Other Drug Abuse Among Adults in the Criminal Justice System. Treatment Improvement Protocol (TIP) Series 7**(1994) 129 pp. **BKD138X**This TIP provides guidelines to criminal justice and substance abuse treatment personnel on effective procedures and instruments to ensure appropriate program referral, treatment, and enhanced outcomes.
**Intensive Outpatient Treatment for Alcohol and Other Drug Abuse. Treatment Improvement Protocol (TIP) Series 8**(1994) 114 pp. **BKD139X**This TIP provides an introductory review of intensive outpatient treatment (IOT), documenting the clinical viability and utility of IOT and stressing the range of IOT services within the broader continuum of care.
**Assessment and Treatment of Patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse. Treatment Improvement Protocol (TIP) Series  9**(Reprint 1995) 114 pp. **BKD134**Volume 9 of the TIP series provides treatment recommendations that are practical and useful for enhancing services to individuals dually diagnosed with mental health and substance abuse problems. 

**Assessment and Treatment of  Cocaine-Abusing, Methadone-Maintained Patients. Treatment Improvement Protocol (TIP) Series 10**(1994) 129 pp. **BKD157**This TIP addresses the treatment needs of methadone patients using opioids and stimulants, especially cocaine and crack-cocaine. 
**Simple Screening Instruments for Outreach for Alcohol and Other Drug Abuse and Infectious Diseases. Treatment Improvement Protocol (TIP) Series 11**(1994) 82 pp. **BKD143X**This TIP presents information on two screening instruments, one for substance abuse and one for infectious diseases, their development, and guidelines for their use. The instruments are designed for linking substance abuse treatment with individuals suffering from HIV/AIDS, TB, and STDs.
**Combining Substance Abuse Treatment with Intermediate Sanctions for Adults in the Criminal Justice System. Treatment Improvement Protocol (TIP) Series 12**(1994) 110 pp. **BKD144X**This photocopied TIP provides the substance abuse treatment and criminal justice systems with information to enhance the linkage of treatment services for offenders assigned to intermediate sanctions. Planning, policy, ethical, and legal issues are discussed.

**The Role and Current Status of Patient Placement Criteria in the Treatment of Substance Use Disorders. Treatment Improvement Protocol (TIP) Series 13**(1995) 84 pp. **BKD161**An objective of the substance abuse treatment field is to establish standardized patient placement criteria (PPC). This TIP will help readers understand what PPC are learned from the experiences of others who have helped develop currently used criteria. It also lays the groundwork for a concerted effort to develop national uniform patient placement criteria. 

**Developing State Outcomes Monitoring Systems for Alcohol and Other Drug Abuse Treatment. Treatment Improvement Protocol (TIP) Series 14**(1995) **BKD162**Volume 14 of this series is designed to help single State agencies and their staff develop, implement, and manage outcomes monitoring systems (OMSs) for local substance abuse treatment programs to increase accountability for treatment expenditures. This TIP will be of interest to anyone who wants to improve patient matching and treatment. 

**Treatment for HIV-Infected Alcohol and Other Drug Abusers. Treatment Improvement Protocol (TIP) Series 15**(1995) **BKD163**All HIV-infected substance abusers, regardless of the setting in which they receive care, should have available to them a spectrum of core services and treatment approaches. This TIP identifies these necessary core services and approaches. It also provides recommendations and guidelines for quality care for substance abusers in treatment who are infected with HIV.  

**Alcohol and Other Drug Screening of Hospitalized Trauma Patients. Treatment Improvement Protocol (TIP) Series 16**(1995) **BKD164**Alcohol and drugs frequently play a significant role  in traumatic injury, especially re-injury. The TIP recommends alcohol and drug screening (blood and urine) of injured patients, ages 14 and older, at hospital admission. A comprehensive substance abuse assessment is outlined, and some brief intervention techniques are described. 
**Planning for Alcohol and Other Drug Abuse Treatment for Adults in the Criminal Justice System. Treatment Improvement Protocol Series 17**(1995) 116 pp. **BKD165**Chapters in volume 17 discuss the effectiveness of substance abuse treatment in the criminal justice system; the offenders and their related issues, such as HIV/AIDS, mental disorders, sexual abuse, and violence; and the substance abuse treatment system overall. The TIP describes how coordination, collaboration, and training can take place and how confidentiality should be handled. 

**The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Abuse Treatment Providers. Treatment Improvement Protocol Series 18**(1995) 132 pp. **BKD173**This TIP describes the tuberculosis disease and modes of transmission, how substance abuse programs can play their part in preventing or treating TB patients, and how TB can be prevented in the workplace. Related issues such as discrimination and confidentiality are discussed. 

**Detoxification From Alcohol and Other Drugs. Treatment Improvement Protocol Series 19**(1995) 94 pp. **BKD172**This TIP covers detoxification settings and patient matching, clinical detoxification protocols, improving quality and measuring outcomes, and costs and current payment mechanisms for detoxification services. Special populations such as women, elderly persons, patients who are HIV positive, and incarcerated persons are also discussed. 

**Matching Treatment to Patient Needs in Opioid Substitution Therapy. Treatment Improvement Protocol (TIP) Series 20**(1995) **BKD168**Persons with addictions to opioids often need a broad range of services in addition to opioid substitution therapy. Research has shown that providing these services as part of the therapy program greatly increases retention in treatment and improves outcomes. This TIP offers guidelines to providers who deliver quality treatment to opiate-addicted persons. 

**Combining Alcohol and Other Drug Abuse Treatment with Diversion for Juveniles in the Justice System. Treatment Improvement Protocol (TIP) Series 21**(1995) 130 pp. **BKD169**This TIP covers the goals of substance abuse treatment-focused diversion program goals, diversion program collaborating, and juvenile diversion to substance abuse treatment planning. 

**LAAM in the Treatment of Opiate Addiction. Treatment Improvement Protocol (TIP) Series 22**(1995) **BKD170**Levo-alpha-acetyl-methadol (LAAM) is an opioid agonist medication approved for use by the Food and Drug Administration in 1993. This TIP describes the medication itself, its modes of action, possible side effects, and interactions with other medications. Separate chapters describe treatment planning, program administration, and regulatory and ethical issues. 

**Treatment Drug Courts: Integrating Substance Abuse Treatment With Legal Case Processing. Treatment Improvement Protocol (TIP) Series 23**(1996) 66 pp. **BKD205**Volume 23 of this TIP will help policymakers and practitioners plan, implement, monitor, and evaluate programs that effectively integrate substance abuse treatment in the pretrial processing of criminal cases. TIP 23 was developed to encourage agencies creating and participating in these programs to share information about their sucesses and failures so that substance abuse treatment will be effectively integrated into pretrial case processing. 

**A Guide to Substance Abuse Services for Primary Care Clinicians. Treatment Improvement Protocol (TIP) Series 24**(1997) 168 pp. **BKD234**This document gives primary care clinicians specific guidance on identifying indications of substance abuse, how to broach the subject with a patient, and what screening and assessment instruments to use. It explains how to perform an office-based brief intervention in which patient and clinician set mutually agreed upon goals and "contract" to stop or cut back the alcohol or other drug use. The TIP also discusses the elements of in-depth assessments, appropriate referrals, and specialized treatment.
*Other Publications Related to TIP 24:*- Guia de Servicios para el Abuso de Sustancias Para Proveedores de Atencion Primaria de la Salud. Serie de Protocolo de Mejora Terapeutica 24: Guia Concisa de Referencia  (1999, CSAT) 30 pp.  MS631S  Esta gu�a concisa de referencia pertenece a la publicaci�n "TIP 24" e incluye informaci�n sobre la evaluaci�n de pacientes adultos referente al abuso de alcohol y drogas. La gu�a ofrece ejemplos de preguntas que se pueden hacer al paciente, y explica qu� se debe hacer cuando abuso de sustancias sea identificado en un paciente. Factores de riesgo e indicadores de posibles problemas de abuso de sustancia tambi�n se discuten. Guide to Substance Abuse Services for Primary Care Clinicians. TIP 24 Concise Desk Reference
(1998, CSAT) 30 pp. 
MS631
This reference guide is a companion piece to TIP 24. The guide includes highlights of TIP 24, providing primary care clinicians with quick, easy access to vital field-related information.
Identifying Substance Abuse in the Primary Care Setting— TIP 24 Pocket Guide
(1998, CSAT) 7 pp. 
MS632
Using information from TIP 24, 
A Guide to Substance Abuse Services for Primary Care Clinicians
, this pocket guide discusses drug and alcohol abuse screening of adult patients. The guide offers sample questions to ask, what to do when substance abuse is identified in a patient, and what risk factors and red flags to look for.
**Substance Abuse Treatment and Domestic Violence. Treatment Improvement Protocol (TIP) Series 25**(1997, CSAT) 152 pp. **BKD239**Designed for treatment providers, this TIP presents an introduction to the field of domestic violence. It offers providers useful information on the role of substance abuse in domestic violence—both among the men who batter and the women who are battered. Useful techniques for detecting and eliciting such information are supplied, along with ways to modify treatment to ensure victims' safety and to stop the cycle of violence in both parties' lives. Legal issues are discussed and the TIP provides a blueprint for a more integrated system of care that would enhance treatment for both problems. 
**Substance Abuse Among Older Adults. Treatment Improvement Protocol (TIP) Series 26**(1998) 173 pp. **BKD250**Adults ages 60 and older tend to be overlooked in discussions of substance abuse, resulting in thousands of older adults who need treatment and do not receive it. This TIP recommends practices for identifying, screening and assessing, and treating alcohol and prescription drug abuse among older adults. TIP 26 is designed for substance abuse treatment providers, primary care clinicians, social workers, and senior center staff.

**Comprehensive Case Management for Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 27**(1998) 121 pp. **BKD251**A history of case management, including models of case management with substance abusers, is provided in this TIP. The TIP also covers case management for clients with special needs, funding case management in managed care environments, and application of case management to substance abuse treatment. 

**Naltrexone and Alcoholism Treatment. Treatment Improvement Protocol (TIP) Series 28**(1998) 94 pp. **BKD268**Naltrexone therapy, in combination with psychosocial programs, can improve alcoholism treatment outcomes. In many patients, naltrexone reduces the urge to drink, giving the patient the opportunity to learn to stay sober without it. This TIP will help clinicians and treatment providers use naltrexone safely and effectively to enhance patient care and improve treatment outcomes.  

**Substance Use Disorder Treatment for People with Physical and Cognitive Disabilities. Treatment Improvement Protocol (TIP) Series 29** (1998) 156 pp. **BKD288**People with physical and cognitive disabilities are more likely to have a substance use disorder and less likely to get effective treatment for it than those without such a coexisting disability. This TIP explains the issues in treating people with coexisting disabilities, discusses how to screen for coexisting disorders and how to adapt substance use screening for clients who have a disability, and examines treatment planning and counseling.

**Screening and Assessing Adolescents for Substance Use Disorders. Treatment Improvement Protocol (TIP) Series 31**(1999) 136 pp. **BKD306**Substance use can disrupt a young person's ability to meet developmental tasks and impair identity development, a central theme of adolescence. This TIP presents information on identifying, screening, and assessing substance use in adolescents. Since adolescents differ from adults physiologically and emotionally, it is important for professionals who come into regular contact with youth to recognize the signs of substance use. The TIP focuses on the most current procedures and instruments for detecting substance abuse among adolescents, conducting comprehensive assessments, and beginning treatment planning.

**Treatment of Adolescents with Substance Use Disorders. Treatment Improvement Protocol (TIP) Series 32**(1999) 126 pp. **BKD307**This TIP presents information on substance use disorder treatment for adolescent clients. Adolescents differ from adults physiologically and emotionally as they make the transition from child to adult and require treatment adapted to their needs. In order to treat this population effectively, treatment providers must address the issues that play significant roles in an adolescent's life, such as cognitive, emotional, physical, social, and moral development, and family and peer environment. The TIP focuses on ways to specialize treatment for adolescents, as well as on common and effective program components and approaches being used today.

**Treatment for Stimulant Use Disorders. Treatment Improvement Protocol (TIP) Series 33**(1999) 226 pp. **BKD289**Stimulant use has risen dramatically in the United States over the last 20 years. This TIP explains the nature and treatment of stimulant use disorders. The TIP also reviews what is currently known about treating the medical, psychiatric, and substance abuse/dependence problems associated with cocaine and methamphetamine use.

**Enhancing Motivation for Change in Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 35**(1999, CSAT) 243 pp. **BKD342**This TIP shows how substance abuse treatment staff can influence change by developing a therapeutic relationship that respects and builds on the client's autonomy and, at the same time, makes the treatment clinician a partner in the change process.

**Substance Abuse Treatment Responding to Child Abuse and Neglect Issues: Treatment Improvement Protocol 36**(2000, CSAT) 181 pp. **BKD343**The effects of childhood abuse and neglect perpetrated by family members and the intergenerational transmission of the cycle of substance abuse and child abuse and neglect are the focus of this TIP. The seven chapters discuss working with child abuse and neglect issues; screening and assessing adults for childhood abuse and neglect; comprehensive treatment for adult survivors; therapeutic issues for counselors; the substance-dependent client as parent/caregiver; legal responsibilities; and emerging and continuing issues. The closing recommendations include screening assessment protocol and issues for counselors.
**Substance Abuse Treatment for Persons with HIV/AIDS: Treatment Improvement Protocol (TIP) Series 37**(CSAT, 2000)  316 pp.  **BKD359**This installment of the Treatment Improvement Protocol (TIP) Series discusses the unique substance abuse treatment needs of a person with HIV/AIDS. Topics covered include a general overview of HIV/AIDS, medical treatment, mental health treatment, primary and secondary modes of HIV prevention, and many other pertinent issues. **Other items related to TIP 37 include:**- Substance Abuse Treatment for Persons with HIV/AIDS: Quick Guide for Clinicians  (CSAT, 2000) 32 pp.  MS678  This small spiral-bound guide serves as a quick reference for clinicians treating people with HIV/AIDS. It gives concise facts about the role of substance abuse treatment for HIV/AIDS patients, and talks about counseling and legal considerations. The guide includes phone and Internet resources and a glossary of HIV/AIDS terms.  **TIP 37 Preview: Substance Abuse Treatment for Persons with HIV/AIDS**(CSAT, 2000) 7 pp. **MS677**TIP 37 Preview gives a brief overview of the upcoming publication Substance Abuse Treatment for Persons with HIV/AIDS. It describes the major topics covered in the TIP and provides the reasons for the production of another resource on HIV/AIDS.Substance Abuse Treatment for Persons with HIV/AIDS: A Clinicians Guide
(CSAT, 2000) 316 pp. 
BKD359C
***Back to Top***
 SAMHSA Managed Care Technical Assistance Series 
**An Evaluation of Contracts Between Managed Care Organizations and Community Mental Health and Substance Abuse Treatment and Prevention Agencies. Volume 1**(1997, SAMHSA) 60 pp. **BKD240**Volume 1 of this series examines the structure and content of provider network agreements between managed care organizations and community mental health and substance abuse treatment and prevention agencies. 

**Designing Substance Abuse and Mental Health Capitation Projects: A Managed Care Guide for State and Local Officials. Volume 3**(1998, SAMHSA) 62 pp. **BKD290**Public sector substance abuse and mental health agencies are helped through the design of quality capitation projects in this guide. The guide also includes a step-by-step approach to becoming a "smart purchaser" of capitated substance abuse and mental health services. This guide is a reference tool that reviews the options available to capitation designers and the relative merits and drawbacks of the alternatives. 

**Estimating and Managing Risks for the Utilization and Cost of Mental Health and Substance Abuse Services in a Managed Care Environment. Volume 4**(1998, SAMHSA) 109 pp. **BKD291***Estimating and Managing Risks* discusses the principles and implementation of risk-sharing provider payment systems used in managed care systems. Sections of the manual discuss such topics as how to measure and manage risk, factors to consider when developing risk estimates, and managing risks after the contract is signed. 

**Ethical Issues for Behavioral Health Care Practitioners and Organizations in a Managed Care Environment. Volume 5**(1998, SAMHSA) 32 pp. **BKD292**This guide explores core ethical issues in managed behavioral health care, including the ethical principles underlying debate regarding the overall allocation of health care resources. Ethical issues confronting the behavioral health care organization in a managed care environment are also discussed.  

**Legal Issues Associated with Development and Implementation of Provider-Sponsored Managed Care Organization. Volume 6**(1998, SAMHSA) 65 pp. **BKD296**Volume 6 in this series summarizes the legal issues that substance abuse service and mental health providers must address when organizing provider-sponsored managed care organizations (MCO's) and when implementing managed care programs through contract negotiation and the delivery of services and care through provider contracts.

**Partners in Planning: Consumers' Role in Contracting for Public-Sector Managed Mental Health and Addiction Services. Volume 10**(1998, SAMHSA) 104 pp. **BKD293**Consumers and families are guided through the process of identifying and advocating for the best possible managed care contracting practices in Volume 10 of this series. Chapters explore the contracting process, the contract content and services, consumer rights, and quality assurance. 
***Back to Top*****

**